The world has yet to see a form of the deadly bird flu virus that could spread easily between people and cause a global outbreak - but that doesn't mean it won't happen, scientists said on Thursday.
After studying 15 years of data on bird flu viruses in the wild, researchers said some strains were already part way along the road to acquiring a handful of mutations needed to change into a form that could cause a devastating human pandemic.
"The remaining... mutations could evolve in a single human host, making a virus evolving in nature a potentially serious threat," Derek Smith of Britain's University of Cambridge, who led the research, told reporters.
Currently, bird flu, or H5N1 avian flu, can be transmitted from birds to birds, and birds to humans, but not from humans to humans. When it does pass from birds to humans, it is usually fatal.
Two earlier studies by researchers in the United States and Europe have found that with as few as five mutations, H5N1 flu can become transmissible in the air between mammals, including potentially from person to person.
Their work was highly controversial because they manipulated viruses in the lab to produce the new mutated strains.
Mutations are already out there
Until now, scientists were not sure whether it was possible these same mutations could evolve in nature.
But Smith's co-researcher Colin Russell said their study, published on Thursday in the journal Science, showed it was.
"Viruses that have two of these mutations are already common in birds, meaning that there are viruses that might have to acquire only three additional mutations in a human to become airborne transmissible," he told reporters.
So far, the H5N1 virus, which was first detected in Hong Kong in 1997, has infected tens of millions of ducks, geese, chickens and other birds. People who have been infected - so far there have been 606, of whom 357 have died - are mostly those who came into close contact with birds.
Last year, teams led by Ron Fouchier at Erasmus Medical Center and by Yoshihiro Kawaoka at the University of Wisconsin managed to create laboratory-enhanced versions of the virus that spread like ordinary flu between mammals.
This type of research is seen as vital for scientists working to develop vaccines, diagnostic tests and anti-viral drugs that could be deployed in the event of an H5N1 pandemic.
But opponents said the work could be misused by terrorists or that the virus might somehow escape from the lab and spread. An international row over the publication of the two papers blew up, leading to a temporary moratorium on such research.
"Active fault line"
Smith likened scientists' current position on the likelihood of an H5N1 human pandemic to that of researchers trying to predict an earthquake.
"We now know that we're living on a fault line," he said. "And what we have discovered in this working collaboration with Fouchier and Kawaoka is that it's an active fault line. It really could do something. We've seen no fundamental hurdle to that happening."
But he said it was impossible to assess the exact risk. "We know it is in the realms of possibility ... and what needs to be done now is to assess the risk more accurately."
In a second H5N1 study published as part of a series on bird flu in Science on Thursday, Rino Rappuoli, a researcher at the Swiss drugmaker Novartis's vaccines and diagnostics unit in Italy, outlined how the world could better prepare for a potential bird flu pandemic.
Among the most important steps, he said, would be to immunise as many people as possible with existing H5N1 vaccines to prime their immune systems and reduce the severity of illness if a pandemic were to happen. There was also a need to ensure manufacturers could make large quantities of a pandemic vaccine quickly by sharing strains and scientific knowledge swiftly across the world.
The deputy minister called on South Sudanese farmers in states that have not been hit by famine to cultivate their farmlands to avoid exacerbating the crisis in the country.
Researchers determined that while the Guinean form of the Ebola virus (EBOV) showed a 97 percent similarity to the Zaire strain, the disease was not introduced from Central Africa.
The Ministry of Environmental Protection found that 82.8 percent of the contaminated samples contained toxic inorganic pollutants, including cadmium, mercury, arsenic, chromium and lead.
Pakistan's army will join campaign to eradicate polio.
Instead of testing one drug at a time, a novel lung cancer study announced will allow British researchers to test up to 14 drugs from AstraZeneca and Pfizer at the same time within one trial
Australian Immigration Minister Scott Morrison's office said that medical officers at the centre had confirmed three cases of the potentially fatal tropical disease, which is transmitted by mosquitoes
The International Court of Justice (ICJ) last month ordered a halt to its annual hunts in the Southern Ocean, prompting Japan to cancel its 2014-2015 Antarctic hunt, the programme's mainstay, as it pledged to abide by the ruling
Researchers said they have identified a protein on the egg cell's surface that interacts with another protein on the surface of a sperm cell, allowing the two cells to join
The Crimean-Congo haemorrhagic fever (CCHF) virus was found in the person's blood who died on Sunday in Istanbul.
Authorities said a cancer-inducing chemical had been found in tap water supplied by the firm at 20 times above national safety levels, state media said
Ebola is a contagious disease for which there is no known treatment or cure.
The central government has identified the heavily industrialised Beijing-Hebei-Tianjin region as one of the main fronts in its war against pollution
The findings of the study and the likely changes to the food chain will be of concern to millions in the tropics who depend on coral reefs for food security and livelihoods.
More compact city designs that cut commutes, insulation to save energy, better public transport, cycle lanes and pedestrian areas can all cut emissions, mainly from fossil fuels.
Along with Saudi Arabia, cases of MERS have so far been reported in Qatar, the United Arab Emirates, Tunisia, Jordan and Oman.
The proposed establishment of an African Center for Disease Control and Prevention, as well as proposals for a centralized regulatory system for medical products, is expected to feature on the conference agenda.